| Provision of Breyanzi CAR POS T-Cells | The Clatterbridge Cancer Centre NHS Foundation Trust | Not published | Not published |
| Provision of Breyanzi CAR POS T-Cells | The Clatterbridge Cancer Centre NHS Foundation Trust | Not published | Not published |
| OPDIVO (NIVOLUMAB) 600MG/5ML SOLUTION FOR INJECTION VIAL, 5 mL | Belfast Health and Social Care Trust | Not published | Not published |
| YERVOY (IPILIMUMAB) CONCENTRATE FOR SOLUTION FOR INFUSION vial, PACK OF 1 | Belfast Health and Social Care Trust | Not published | Not published |
| Provision of Breyanzi CAR POS T-Cells | The Clatterbridge Cancer Centre NHS Foundation Trust | Not published | £140,250 |
| Provision of Breyanzi CAR POS T-Cells | The Clatterbridge Cancer Centre NHS Foundation Trust | Not published | Not published |
| Provision of Breyanzi CAR POS T-Cells | The Clatterbridge Cancer Centre NHS Foundation Trust | Not published | Not published |
| Provision of Breyanzi CAR POS T Cells | The Clatterbridge Cancer Centre NHS Foundation Trust | Not published | Not published |
| Provision of Breyanzi CAR POS T Cells | The Clatterbridge Cancer Centre NHS Foundation Trust | Not published | Not published |
| Provision of CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) products | Barts Health NHS Trust | Not published | £2,100,000 |